ArticleBioengineering (Basel, Switzerland)2025

Development and Characterization of CD44-Targeted X-Aptamers with Enhanced Binding Affinity for Cancer Therapeutics.

Hongyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.